Ajanta Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

3,971.12

3,411.27

3,140.64

2,718.59

2,196.42

Operating profit

1,119.43

650.98

890.89

916.91

532.78

Interest

6.80

5.23

9.12

6.90

9.10

Gross profit

1,229.11

826.80

1,021.50

1,013.58

707.88

EPS (Rs)

63.89

44.22

83.85

77.70

50.30

Other income

116.48

181.05

139.73

103.57

184.20

Stock adjustment

-22.17

-21.99

-56.60

-74.60

9.02

Raw material

939.43

878.36

773.04

704.09

556.22

Power and fuel

-

-

-

-

-

Employee expenses

834.16

720.41

585.87

498.11

437.82

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1,100.27

1,183.51

947.44

674.08

660.58

Provisions made

-

-

-

-

-

Depreciation

132.16

126.95

120.96

111.49

91.29

Taxation

289.71

141.13

180.68

226.45

171.54

Net profit / loss

807.24

558.72

719.86

675.64

441.13

Extra ordinary item

-

-

-

-

-3.92

Prior year adjustments

-

-

-

-

-

Equity capital

25.27

25.27

17.17

17.39

17.54

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.19

19.08

28.37

33.73

24.26

GPM (%)

30.07

23.02

31.14

35.92

29.74

NPM (%)

19.75

15.55

21.94

23.94

18.53